Exosomes in Cardiovascular Disease: Emerging Roles, Therapeutic Potential and Translational Challenges
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Adnan Taan Al Khafaji und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Al-Ayen Iraqi University, An Nasiriyah, Iraq. Hauptthemen laut MEDLINE: Exosomes, Cardiovascular Diseases. Die Arbeit nennt 135 Literaturangaben.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) remain a leading global cause of mortality, necessitating novel therapeutic strategies to address myocardial injury, adverse remodelling and impaired cardiomyocyte regeneration. Exosomes, nanoscale extracellular vesicles secreted by nearly all cell types, have emerged as pivotal mediators of intercellular communication, influencing cardiac physiology and pathology through their cargo of nucleic acids, proteins and lipids. These vesicles participate actively in processes such as cytoprotection, angiogenesis, apoptosis regulation and immune modulation, which are critical for cardiac repair and regeneration. Recent preclinical and clinical studies highlight the promising regenerative capabilities of exosomes, especially those derived from stem cells and immune cells, positioning them as innovative therapeutic tools and diagnostic biomarkers in CVD management. Despite their potential advantages over traditional cell therapies, including lower immunogenicity and enhanced targeting, several hurdles remain before exosomes can be routinely applied in clinical practice. Challenges include the lack of standardized isolation and characterization protocols, heterogeneity of exosome populations, inefficient cargo loading methods, off‐target biodistribution and safety concerns related to immune response and infectious risk. Ongoing research aims to overcome these obstacles to realize exosomes' full potential in cardiovascular regenerative medicine, with diagnostic applications currently representing a nearer‐term goal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Al-Ayen Iraqi University, An Nasiriyah, Iraq.
- Ministry of Health, Nasr City Hospital for Health Insurance, Cairo, Egypt.
ORCID-Profile: Ali Mohammed Barakat
Zitieren
APA
Khafaji, A. T. A., Barakat, A. M., Zaidy, A. J. A., Taan, A. A., & Al-Aouadi, R. F. A. (2025). Exosomes in Cardiovascular Disease: Emerging Roles, Therapeutic Potential and Translational Challenges. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70151
Vancouver
Khafaji ATA, Barakat AM, Zaidy AJA, Taan AA, Al-Aouadi RFA. Exosomes in Cardiovascular Disease: Emerging Roles, Therapeutic Potential and Translational Challenges. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70151
BibTeX
@article{Khafaji2025,
author = {Khafaji, Adnan Taan Al and Barakat, Ali Mohammed and Zaidy, Akram Jooda Al and Taan, Ali Adnan and Al-Aouadi, Raed Fanoukh Aboqader},
title = {Exosomes in Cardiovascular Disease: Emerging Roles, Therapeutic Potential and Translational Challenges},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70151}
}
EUVIMED